Showing 1 - 9 results of 9 for search 'Fengwu Chen', query time: 0.03s
Refine Results
-
1
Gut microbes regulate the feeding center: a new discovery of Gut Brain Axis by Fengwu Chen, Kaijian Hou, Zhe-Sheng Chen
Published 2022-08-01
Article -
2
Fecal microbiota transplantation treatment of autoimmune-mediated type 1 diabetes: A systematic review by Shuo Zhang, Shuo Zhang, Feiying Deng, Feiying Deng, Jingxian Chen, Jingxian Chen, Fengwu Chen, Fengwu Chen, Zezhen Wu, Zezhen Wu, Liping Li, Kaijian Hou, Kaijian Hou
Published 2022-12-01
Article -
3
Pharmacoeconomic analysis (CER) of Dulaglutide and Liraglutide in the treatment of patients with type 2 diabetes by Yu Su, Shuo Zhang, Shuo Zhang, Shuo Zhang, Zezhen Wu, Zezhen Wu, Zezhen Wu, Weiting Liu, Jingxian Chen, Jingxian Chen, Feiying Deng, Feiying Deng, Feiying Deng, Fengwu Chen, Fengwu Chen, Dan Zhu, Kaijian Hou
Published 2023-01-01
Article -
4
Fecal microbiota transplantation reverses insulin resistance in type 2 diabetes: A randomized, controlled, prospective study by Zezhen Wu, Zezhen Wu, Zezhen Wu, Bangzhou Zhang, Bangzhou Zhang, Fengwu Chen, Fengwu Chen, Rongmu Xia, Dan Zhu, Baolong Chen, Aiqiang Lin, Chuyan Zheng, Ducheng Hou, Xiaoyu Li, Shuo Zhang, Shuo Zhang, Shuo Zhang, Yongsong Chen, Kaijian Hou, Kaijian Hou, Kaijian Hou
Published 2023-01-01
Article -
5
Expression of SALL4 in the synovial tissue of refractory rheumatoid arthritis patients by Ru Fan, Zeqiong Liang, Yujie Bu, Fen Zhang, Xing Cen, Yuqing Liu, Fenping Lian, Fengwu Chen, Shengxiao Zhang, Junwei Chen
Published 2024-03-01
Article -
6
-
7
The global, regional and national burden of type 2 diabetes mellitus in the past, present and future: a systematic analysis of the Global Burden of Disease Study 2019 by Junjun Ye, Junjun Ye, Yixi Wu, Yixi Wu, Shuhui Yang, Dan Zhu, Fengwu Chen, Jingxian Chen, Jingxian Chen, Xiaoxia Ji, Kaijian Hou, Kaijian Hou
Published 2023-07-01
Article -
8
Efficacy of polyethylene glycol loxenatide versus insulin glargine on glycemic control in patients with type 2 diabetes: a randomized, open-label, parallel-group trial by Shuo Zhang, Shuo Zhang, Shuo Zhang, Chuanyan Zhang, Chuanyan Zhang, Jingxian Chen, Jingxian Chen, Feiying Deng, Feiying Deng, Zezhen Wu, Zezhen Wu, Dan Zhu, Fengwu Chen, Yale Duan, Yue Zhao, Kaijian Hou, Kaijian Hou, Kaijian Hou
Published 2023-05-01
Article -
9
Real-world effectiveness of GLP-1 receptor agonist-based treatment strategies on “time in range” in patients with type 2 diabetes by Yongru Chen, Jingxian Chen, Jingxian Chen, Shuo Zhang, Shuo Zhang, Dan Zhu, Feiying Deng, Feiying Deng, Rui Zuo, Yufei Hu, Yue Zhao, Yale Duan, Benwei Lin, Fengwu Chen, Yun Liang, Jiaxiong Zheng, Barkat Ali Khan, Kaijian Hou
Published 2024-03-01
Article